Factors Influencing Mpox Vaccine Acceptance and Reluctance Among Healthcare Professionals in Port Harcourt, Nigeria - Top-Institutions - MDSpire

Factors Influencing Mpox Vaccine Acceptance and Reluctance Among Healthcare Professionals in Port Harcourt, Nigeria

  • By

  • Moore Ikechi Mike-Ogburia

  • Chiziyara Orluibna Obunwo

  • Elizabeth Efeelobari Letam

  • Ayebaemi Wilfred Dambo

  • Samuel Chima Agumagu

  • Tamunosaki Fubara-Manuel

  • Charles Henry Esukpa

  • February 26, 2026

  • 0 min

Share

Top Institutions in Infectious Disease

Brief introduction explaining scope and methodology.

  • #1

    Centers for Disease Control and Prevention (CDC)
    Centers for Disease Control and Prevention (CDC)

    Atlanta, GA

    Key Differentiators

    • Infectious Diseases
    • Epidemiology
    • Vaccine Research

  • #2

    London School of Hygiene & Tropical Medicine (LSHTM)
    London School of Hygiene & Tropical Medicine (LSHTM)

    London, N/A

    Key Differentiators

    • Infectious Disease Epidemiology
    • Global Health
    • Vaccine Hesitancy Research

  • #3

    National Institute for Communicable Diseases (NICD), South Africa
    National Institute for Communicable Diseases (NICD), South Africa

    Johannesburg, N/A

    Key Differentiators

    • Infectious Diseases
    • Public Health Surveillance
    • Vaccine Policy

  • #4

    University of Ibadan, College of Medicine
    University of Ibadan, College of Medicine

    Ibadan, Oyo

    Key Differentiators

    • Infectious Diseases
    • Public Health
    • Vaccine Research in Nigeria

  • #5

    Johns Hopkins Bloomberg School of Public Health
    Johns Hopkins Bloomberg School of Public Health

    Baltimore, MD

    Key Differentiators

    • Public Health
    • Infectious Disease Epidemiology
    • Behavioral Science

Original Source(s)

Factors Influencing Mpox Vaccine Acceptance and Reluctance Among Healthcare Professionals in Port Harcourt, Nigeria

  • by Moore Ikechi Mike-Ogburia, Chiziyara Orluibna Obunwo, Elizabeth Efeelobari Letam, Ayebaemi Wilfred Dambo, Samuel Chima Agumagu, Tamunosaki Fubara-Manuel, Charles Henry Esukpa

  • February 26, 2026

Related Content

A Chlamydia trachomatis CPAF-STING agonist conjugate vaccine administered intramuscularly and intradermally is immunogenic in the pig model

31 Live Births Reported Following Uterus Transplant

Single-center series details maternal, obstetric, and neonatal outcomes among recipients with uterine-factor infertility

RSV Prevention Tied to Lower Infant Acute Care Use

Data suggest fewer respiratory syncytial virus–associated hospitalizations and emergency department visits among the youngest infants during the second season of routine prevention product use.